Share of Voice Is Not Built in Moments. It Is Built Over Time. Broadcast-led programme formats designed to build sustained presence in complex disease areas.
Consistent, broadcast-led programme formats designed to build sustained presence and authority in complex disease areas.
Move beyond one-off campaigns to consistent, recognisable formats that build authority over time.
Editorially led, professionally produced programmes that stand apart from traditional webinars.
Global clinical and scientific voices contributing to credible, ongoing dialogue.
Live, episodic, congress-adjacent, or studio-based — designed to work across markets and audiences.
Pharmaceutical organisations understand reach. Most of the industry has become skilled at showing up at congress, at launch events, and through digital campaigns.
What remains genuinely difficult is sustaining presence between those moments — maintaining visibility in a disease area when there is no news event to anchor the conversation.
This is the problem that Clanmac Broadcast was designed to solve.
A campaign creates a spike. A programme creates a presence.
Share of voice is not built in a single moment. It is accumulated through consistent, credible, expert-led conversation over time. Audiences — whether HCPs, payers, or policy stakeholders — form their perception of scientific leadership through repeated engagement, not one-off exposure.
Branded programmes replace isolated content assets with a recognisable, repeatable format — one that audiences expect, experts return to, and authority builds through over time.
Our broadcast programme approach builds sustained visibility, credibility, and engagement across scientific and healthcare audiences.
Our team of former broadcast journalists, producers, and strategists delivers communications that are not only accurate and compliant, but also compelling and memorable.
Broadcast-led formats designed to deliver consistent, high-quality engagement across channels and markets.
We do not create isolated content assets.
Every programme is designed as part of a broader content ecosystem — built around the disease area, the science, and the audience it needs to reach.
Our work is grounded in broadcast principles: strong editorial structure, credible expert voices, and production quality that reflects the importance of the subject matter.
We plan content strategically — often months in advance — identifying the right stories, contributors, and formats, then capturing multiple assets in a single production cycle.
This approach reduces inefficiency, increases output, and ensures that content remains consistent, relevant, and usable over time.
The result is not just content — but a sustained, scalable presence.
Clanmac Media brings broadcast expertise into pharmaceutical communications — helping organisations move from isolated campaigns to sustained, credible presence.
We design formats that build engagement over time, not just one-off visibility.
Content structured like real programmes — not corporate messaging disguised as content.
Designed to engage HCPs, payers, and policy audiences with credibility.
A policy-driven cardiovascular environment where price dominated the conversation.
A launch environment that kept changing.
A disease area that needed consistent presence.
A film brief with no easy answers: communicate complex oncology science at global scale with both emotional and scientific integrity.
A complex medical plan that was not landing.
A disease area that needed a voice it could sustain.
Some rooms are not neutral.
Stakeholders arrive with entrenched positions, competing priorities, and sometimes a structural incentive to say no.
Some launches are complex. This one was in a category of its own.
A groundbreaking gene therapy — the kind that reframes what medicine can do — was entering a global market that was not ready for it.
